Debulking Effect of Curretage on Basal Cell Carcinomas - a Histological Assessment.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00237107
First received: October 10, 2005
Last updated: July 18, 2016
Last verified: July 2016
  Purpose
The aim of this study was to compare histologically observed tumour infitration of basal cell carcinoma (bcc) lesions before and after curretage.A significant reduction of tumour depth would enable further bcc's included for superficial non-invasive treatment modalities such as topical photodynamic therapy.

Condition Intervention
Carcinoma, Basal Cell
Procedure: Curretage

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Relation of Basal Cell Carcinoma Tumour Thickness, Histologically Estimated, in Punch Biopsies Performed Before and After Curretage.

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Reduction of tumour thickness 0,5mm or more after curretage [ Time Frame: 1 hour ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Comparison of tumour thickness in punch biopsies performed on referral, before and after curretage. [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Enrollment: 36
Study Start Date: April 2002
Study Completion Date: December 2004
Primary Completion Date: December 2004 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: curettage Procedure: Curretage

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • bcc with tumour depth two mm.or more

Exclusion Criteria:

  • bcc tumours smaller than three mm in mean diameter.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00237107

Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Principal Investigator: Eidi Christensen, MD St. Olav University Hospital, Trondheim
  More Information

Publications:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00237107     History of Changes
Other Study ID Numbers: EC-003 
Study First Received: October 10, 2005
Last Updated: July 18, 2016
Health Authority: Norway:National Committee for Medical and Health Research Ethics
Individual Participant Data  
Plan to Share IPD: No

Keywords provided by Norwegian University of Science and Technology:
Cytoreduction Surgical Procedures
Curretage
Photochemotherapy

Additional relevant MeSH terms:
Carcinoma
Carcinoma, Basal Cell
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Basal Cell

ClinicalTrials.gov processed this record on July 28, 2016